Start from your own sofa
The health intake is completed at home, on your own schedule. There is no waiting room and no day off work.
Semaglutide [object Object]/mo or tirzepatide [object Object]/mo, reviewed by a Nebraska-licensed provider. Start from Omaha, Lincoln, Grand Island, Kearney or anywhere in the Panhandle — no clinic visit, and medication ships discreetly if prescribed.
Flat monthly price in Nebraska
Semaglutide
$169/mo
Tirzepatide
$219/mo
Cash-pay pricing shown before checkout. Surfbound does not accept insurance. Compounded medications are prepared by state-licensed compounding pharmacies and are not FDA-approved.
Licensed review
State-licensed provider
Flat price
Same at every dose
No clinic visit
Entirely online
Ships if prescribed
Discreet delivery
Two options, one flat monthly price each — the same in Omaha and Lincoln as in the rural counties between them. The price covers the licensed provider review, the medication if it is prescribed, and discreet shipping.
The GLP-1 most people ask about first.
$169 / month
A dual-agonist option, also reviewed by a Nebraska provider.
$219 / month
What it actually feels like
No commute, no waiting room, no insurance call centre. These are the three things that tend to matter most when people weigh it up.
The health intake is completed at home, on your own schedule. There is no waiting room and no day off work.
If treatment is prescribed, it ships discreetly. The packaging does not announce what is inside.
The monthly price does not climb as a dose increases, and there is no separate membership fee.
“Super easy to get approved everything was done less than 24 hours reasonably priced medications”
“Quick, easy and very reliable! I would recommend this provider 100%”
“Easy to do business with, will recommend”
Reviews are shown exactly as published on Google and describe individual experiences. They are not a claim about typical results, and medication is prescribed only when a licensed provider determines treatment is medically appropriate. Surfbound has no physical offices in Nebraska.
Yes. Adults in Nebraska can complete a GLP-1 weight-loss evaluation with Surfbound entirely online. A provider licensed by the Nebraska Board of Medicine and Surgery reviews your health intake under the Nebraska Telehealth Act and, if treatment is medically appropriate, a prescription may be sent to a licensed compounding pharmacy and shipped discreetly to your Nebraska address. Semaglutide is $169/mo and tirzepatide is $219/mo. A prescription is never guaranteed.
In short
Care is delivered online statewide, so where you live in Nebraska only changes where the medication ships. Omaha and Lincoln are the largest referral clusters; Grand Island, Kearney and the more remote counties to the west are served through the same online intake and a licensed compounding pharmacy rather than a local clinic. Rural beyond Omaha and Lincoln with limited specialists. Online review bridges Nebraska's distances.
Anywhere else in Nebraska works the same way — the local pages above simply carry city-specific detail. You can also read the Nebraska provider access and process page.
Four steps, no waiting room. Nebraska permits telemedicine prescribing once a provider–patient relationship has been established, and the state participates in the Interstate Medical Licensure Compact, which helps our providers hold Nebraska licensure alongside their home-state credentials.
Complete the online health intake from Omaha, Lincoln, Grand Island, or anywhere in Nebraska.
A Nebraska-licensed provider reviews your medical information.
If treatment is medically appropriate, a prescription is sent to a licensed compounding pharmacy.
Medication ships discreetly to your Nebraska address.
One flat monthly price covers the licensed provider review, the medication if it is prescribed, and discreet shipping. There is no separate membership fee, and a prescription is issued only when a provider licensed in Nebraska determines treatment is medically appropriate.
The honest comparison
In-person care is the right choice for some people. If you are weighing it up, this is the difference in how the two actually work — not a claim that one is better medicine.
A prescription is not guaranteed — a provider licensed in Nebraska decides whether treatment is medically appropriate, and can decline. The medication offered is compounded by a state-licensed pharmacy and is not FDA-approved. Surfbound does not bill insurance, so the price you see is the price you pay, in cash.
Answer the health questions online, have a Nebraska-licensed provider review them, and — only if treatment is appropriate — receive medication at your door. Semaglutide $169/mo, tirzepatide $219/mo.
Surfbound is an online service with no physical offices in Nebraska. A prescription is not guaranteed and is issued only when a provider determines treatment is medically appropriate.
What governs a provider treating a Nebraska patient online, and where you can check it yourself.
Nebraska Board of Medicine and Surgery licenses the providers who review Nebraska intakes. The board site carries the current licensing and practice requirements.
Opens the official Nebraska code. Search the statute or rule named above for the full text rather than relying on any summary.
A clinician must hold an active Nebraska license to evaluate or treat a patient who is physically located in Nebraska. Every Nebraska intake is routed to a provider credentialed in Nebraska, and a prescription is issued only when that provider determines treatment is medically appropriate.
Nebraska permits telemedicine prescribing when a provider-patient relationship has been established. The state has adopted the Interstate Medical Licensure Compact to facilitate multi-state telehealth practice.
Practical answers about where you can start, how shipping works, and how to compare the complete cost in Nebraska. The Nebraska provider access page covers the clinical steps in detail.
Surfbound lists 6 Nebraska cities with a dedicated local page. Because care is delivered online, you can start from anywhere in Nebraska — the city list is a navigation aid, not a limit on where you can begin.
The Nebraska telehealth page explains how the online provider review works, what to prepare before your review, and how prescriptions and provider switches are handled. This coverage page links to it so you have one process reference and one coverage reference.
No. Surfbound is an online service with no physical offices in Nebraska. You complete a health intake online, and a licensed provider credentialed in Nebraska reviews your information remotely.
Nebraska permits telehealth review and prescribing when a proper provider-patient relationship is established, which the online intake and review process does. A provider licensed in Nebraska may review a Nebraska patient remotely and prescribe only when treatment is medically appropriate. The licensing board, the telehealth statute or rule, and the licensure requirement are listed in the “Telehealth rules in Nebraska” section on this page.
Check the two credentials separately. The reviewing clinician must hold an active Nebraska license issued by the Nebraska Board of Medicine and Surgery, and any pharmacy filling your prescription must be licensed in Nebraska. Both are public lookups — the board and the telehealth statute or rule that govern them are linked in the “Telehealth rules in Nebraska” section on this page.
Nebraska residents pay $169/mo for compounded semaglutide or $219/mo for compounded tirzepatide, provider review included. Compounded medications are not FDA-approved, and the price is displayed before you pay.
If a provider determines treatment is medically appropriate, a prescription may be sent to a licensed compounding pharmacy and medication ships discreetly. Shipping is included; timing depends on pharmacy processing, your location, weekends, and holidays, and tracking is provided.
No. A prescription for a Nebraska patient is issued only when a licensed Nebraska provider determines treatment is medically appropriate after reviewing the health intake.
Yes. Nebraska patients already taking a GLP-1 can request a dose match when clinically appropriate. Sign up and use the doctor-notes field at the end of the form to list your current medication and dose, and whether you want to stay at that dose or discuss increasing it. Your Nebraska-licensed clinician reviews the request and determines the prescription. No written quote is required to switch.
For Nebraska patients, the honest comparison is all-in monthly cost at the same dose. The GLP-1 total-cost calculator normalises membership, shipping and titration fees against one flat published rate.
Compounded semaglutide is one of the two GLP-1 options available across Nebraska, priced flat each month with the provider review included. Nothing ships unless a Nebraska-licensed provider approves treatment. It is not an FDA-approved medication.
Compounded tirzepatide is part of the Nebraska offering, priced flat each month with delivery included. Whether it is the right option is a clinical decision made by a Nebraska-licensed provider, and it is not an FDA-approved medication.
Yes. Oral semaglutide and oral tirzepatide are listed options alongside the compounded injectables, and Nebraska residents are reviewed the same way for either route. Whether an oral option is appropriate is decided by the Nebraska-licensed provider during your review, and oral pricing is shown on those product pages.
No insurer's approval is required to start in Nebraska. Surfbound is cash-pay: semaglutide is $169/mo and tirzepatide is $219/mo, the provider review is included, and there is no separate membership fee. Nothing is charged unless a licensed Nebraska provider approves your medication. Rural beyond Omaha and Lincoln with limited specialists.
Yes. Nebraska residents priced out of a brand-name GLP-1 can be reviewed for compounded semaglutide or tirzepatide. A licensed Nebraska provider decides what may be appropriate, and one flat monthly price applies with no dose-based upcharge. Compounded medications are not FDA-approved versions of Wegovy or Zepbound.
Many people across Nebraska with PCOS, insulin resistance, or prediabetes explore compounded GLP-1 treatment because brand-name coverage for these uses is often denied. A Nebraska-licensed provider reviews your full history to decide whether treatment is medically appropriate. Compounded medications are not FDA-approved.
Yes. Nebraska residents complete a short online intake on their own schedule, and a Nebraska-licensed provider reviews it remotely. If prescribed, medication ships to your door — no clinic, waiting room, or daytime appointment. Rural beyond Omaha and Lincoln with limited specialists. Online review bridges Nebraska's distances.
Yes. Men across Nebraska begin with a private online intake, a licensed Nebraska provider reviews their history remotely, and if prescribed, medication ships in plain, discreet packaging. There is no waiting room, no in-person visit, and no pharmacy-counter pickup.
Yes. Surfbound support reaches Nebraska residents by text/SMS, email (hello@surfbound.co), and phone — new patients at (941) 315-5217 (Monday–Friday, 9:00 AM–5:00 PM ET) and existing patients at (813) 532-3185 (Monday–Friday, 9:00 AM–5:00 PM MST). You can ask about your plan, dosing, or shipping without booking another appointment.
Surfbound providers are licensed to practice in Nebraska and follow applicable state medical board rules for telehealth. The following authoritative sources inform our treatment information.
Official Nebraska state government agency. Provider licensure in Nebraska is governed by the Nebraska Board of Medicine and Surgery.
A prescription is not guaranteed and is issued only when a licensed provider determines treatment is medically appropriate.
Answer the health questions online, have a Nebraska-licensed provider review them, and — only if treatment is medically appropriate — receive medication at your Nebraska address. Semaglutide $169/mo, tirzepatide $219/mo.
Surfbound is an online service. We do not have physical offices in Nebraska. Licensed providers review health information online. A prescription is not guaranteed and is issued only when a provider determines treatment is medically appropriate.